CEREBROLYSIN 5 amp 5ml (complex of natural peptides)

CEREBROLYSIN contains low molecular weight biologically active neuropeptides that penetrate the BBB and directly enter the nerve cells. The bioregulator has an organ-specific multimodal effect on the brain, i.e. provides metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity.

• Metabolic regulation. Cerebrolysin® increases the efficiency of aerobic energy metabolism in the brain, improves intracellular protein synthesis in the developing and aging brain.
• Neuroprotection. Cerebrolysin® protects neurons from the damaging effects of lactic acidosis, prevents the formation of free radicals, increases survival and prevents neuronal death under conditions of hypoxia and ischemia, reduces the damaging neurotoxic effect of excitatory amino acids (glutamate).
• Neurotrophic activity. Cerebrolysin® is the only nootropic peptidergic bioregulator with a proven neurotrophic activity similar to that of natural neuronal growth factors (NGF), but manifested under conditions of peripheral administration.
• Functional neuromodulation. Cerebrolysin® has a positive effect on cognitive impairment, improves memory processes.

Indications:

Alzheimer's disease, dementia syndrome of various origins, chronic cerebrovascular insufficiency, ischemic stroke, traumatic injuries of the brain and spinal cord; mental retardation in children, hyperactivity and attention deficit in children; in complex therapy - with endogenous depression resistant to antidepressants.

Ingredients:

1 ml of solution contains:
active substance: Cerebrolysin® concentrate (a complex of peptides obtained from the brain of a pig) 215.2 mg;
excipients: sodium hydroxide, water for injection.

Effect:

The complex composition of Cerebrolysin, the active fraction of which consists of a balanced and stable mixture of biologically active oligopeptides with a total polyfunctional effect, does not allow for the usual pharmacokinetic analysis of individual components.

Dosage and administration:

It is applied parenterally. Doses and duration of treatment depend on the nature and severity of the disease, as well as on the age of the patient. It is possible to prescribe single doses, the value of which can reach 50 ml, but it is more preferable to conduct a course of treatment.
The recommended optimal course of treatment is daily injections for 10-20 days.
• Acute conditions (ischemic stroke, traumatic brain injury, complications of neurosurgical operations): 10 ml - 50 ml
• In the residual period of cerebral stroke and traumatic injury to the brain and spinal cord: 5 ml - 50 ml
• With psychoorganic syndrome and depression: 5 ml - 30 ml
• In Alzheimer's disease, dementia of vascular and combined Alzheimer's-vascular genesis:  5 ml - 30 ml
• In neuropediatric practice: 0.1-0.2 ml/kg of body weight
To increase the effectiveness of treatment repeated courses can be carried out as long as there is an improvement in the patient's condition due to treatment.
After the first course, the frequency of prescribing doses can be reduced to 2 or 3 times a week.
Cerebrolysin is used as an injection: intramuscularly (up to 5 ml) and intravenously (up to 10 ml).
Doses from 10 ml to 50 ml are recommended to be administered only by slow intravenous infusions after dilution with the proposed standard solutions for infusion.
The duration of the infusion is from 15 to 60 minutes.

Storage temperature: 2℃ to 25℃

Special storage conditions:

Store in a place protected from light at a temperature not exceeding 25°C.
Keep out of the reach of children!
Note: after opening the ampoule, the solution should be used immediately.

Guaranteed authenticity and quality:

100% Original from EVER PHARMA JENA / EVER NEURO PHARMA 

Development and production:

EVER PHARMA JENA / EVER NEURO PHARMA